
ImmunoGenes can help you develop new antibody based therapeutics, antibody based diagnostics or novel genetically modified animals (mice, rats, rabbits) for pre-clinical studies. ImmunoGenes owns a patented technology, which provides enhanced immune response and thus greater possibility to produce the right antibody, than the usually used techniques. Our team consists of leading experts in the field of transgenesis, and collaborates with some of the leaders in this field- including, but not limited to The Roslin Institute of the University of Edinburgh, INRA-France, LFB-Group and PolyGene AG.…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.